Kaiyuan Wang

机构：Shenyang Pharmaceutical University, National University of Singapore, East China Normal University · ORCID：0000-0001-9567-1410

发表论文 17 篇 · 总被引 284 次 · h-index 8

代表论文

• Programmable human histone phosphorylation and gene activation using a CRISPR/Cas9-based chromatin kinase (2021 · Nature Communications · 被引 82)
• Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer–promoter interactions (2022 · Nucleic Acids Research · 被引 59)
• Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control (2023 · Nature Methods · 被引 44)
• Stable DNA-based reaction–diffusion patterns (2017 · RSC Advances · 被引 35)
• Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions (2019 · BioMed Research International · 被引 13)
• Long-read sequencing of 945 Han individuals identifies structural variants associated with phenotypic diversity and disease susceptibility (2025 · Nature Communications · 被引 12)